Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

100.0%

3 terminated/withdrawn out of 3 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05347108Withdrawn

Real-Time Accurate Pathology Inspection and Decompression Study

Role: lead

NCT03417973Terminated

Quality of Life and Pain Changes Due to DRG Stimulation for Chronic Pain

Role: lead

NCT03421951Terminated

Change in Pain and Quality of Life Following SCS for Chronic Pain

Role: lead

All 3 trials loaded